Search Results - "MAY, Hui"

Refine Results
  1. 1

    The Mouse Action Recognition System (MARS) software pipeline for automated analysis of social behaviors in mice by Segalin, Cristina, Williams, Jalani, Karigo, Tomomi, Hui, May, Zelikowsky, Moriel, Sun, Jennifer J, Perona, Pietro, Anderson, David J, Kennedy, Ann

    Published in eLife (30-11-2021)
    “…The study of naturalistic social behavior requires quantification of animals' interactions. This is generally done through manual annotation-a highly…”
    Get full text
    Journal Article
  2. 2

    Viral Vectors for Neural Circuit Mapping and Recent Advances in Trans-synaptic Anterograde Tracers by Xu, Xiangmin, Holmes, Todd C., Luo, Min-Hua, Beier, Kevin T., Horwitz, Gregory D., Zhao, Fei, Zeng, Wenbo, Hui, May, Semler, Bert L., Sandri-Goldin, Rozanne M.

    Published in Neuron (Cambridge, Mass.) (23-09-2020)
    “…Viral tracers are important tools for neuroanatomical mapping and genetic payload delivery. Genetically modified viruses allow for cell-type-specific targeting…”
    Get full text
    Journal Article
  3. 3

    The Neuropeptide Tac2 Controls a Distributed Brain State Induced by Chronic Social Isolation Stress by Zelikowsky, Moriel, Hui, May, Karigo, Tomomi, Choe, Andrea, Yang, Bin, Blanco, Mario R., Beadle, Keith, Gradinaru, Viviana, Deverman, Benjamin E., Anderson, David J.

    Published in Cell (17-05-2018)
    “…Chronic social isolation causes severe psychological effects in humans, but their neural bases remain poorly understood. 2 weeks (but not 24 hr) of social…”
    Get full text
    Journal Article
  4. 4

    A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease by Prins, Niels D, Harrison, John E, Chu, Hui-May, Blackburn, Kelly, Alam, John J, Scheltens, Philip, Rowell, Zarate, Norden, Van

    Published in Alzheimer's research & therapy (27-05-2021)
    “…Abstract Background In preclinical studies, p38⍺ kinase is implicated in Alzheimer’s disease (AD) pathogenesis. In animal models, it mediates impaired synaptic…”
    Get full text
    Journal Article
  5. 5

    The Application of microRNAs in Biomaterial Scaffold‐Based Therapies for Bone Tissue Engineering by Arriaga, Marco A., Ding, MayHui, Gutierrez, Astrid S., Chew, Sue Anne

    Published in Biotechnology journal (01-10-2019)
    “…In recent years, the application of microRNAs (miRNAs) or anti‐microRNAs (anti‐miRNAs) that can induce expression of the runt‐related transcription factor 2…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies by Alam, John J., Maruff, Paul, Doctrow, Susan R., Chu, Hui-May, Conway, Jennifer, Gomperts, Stephen N., Teunissen, Charlotte

    Published in Neurology (24-10-2023)
    “…BACKGROUND AND OBJECTIVESIn a proportion of patients, dementia with Lewy bodies (DLB) is associated with Alzheimer disease (AD) copathology, which is linked to…”
    Get full text
    Journal Article
  9. 9

    Defining the interconnectivity of the medial prefrontal cortex and ventral midbrain by Hui, May, Beier, Kevin T.

    Published in Frontiers in molecular neuroscience (22-07-2022)
    “…Dysfunction in dopamine (DA) signaling contributes to neurological disorders ranging from drug addiction and schizophrenia to depression and Parkinson’s…”
    Get full text
    Journal Article
  10. 10

    Antiviral activity of telaprevir (VX‐950) and peginterferon alfa‐2a in patients with hepatitis C by Forestier, Nicole, Reesink, Hendrik W., Weegink, Christine J., McNair, Lindsay, Kieffer, Tara L., Chu, HuiMay, Purdy, Susan, Jansen, Peter L.M., Zeuzem, Stefan

    Published in Hepatology (Baltimore, Md.) (01-09-2007)
    “…Telaprevir (VX‐950), an inhibitor of the hepatitis C virus (HCV) NS3/4A protease, substantially decreased plasma HCV RNA levels in a prior clinical study. The…”
    Get full text
    Journal Article
  11. 11

    Pharmacometrics of clobazam in pediatrics: Prediction of effective clobazam doses for Dravet syndrome by Tolbert, Dwain, Chu, Hui-May, Ette, Ene I.

    Published in Epilepsy research (01-11-2019)
    “…•An efficacious pediatric clobazam (CLB) dosing regimen identified by PopPK modeling.•Evaluation/validation showed the model adequately described CLB and N-CLB…”
    Get full text
    Journal Article
  12. 12

    An exploratory clinical study of p38α kinase inhibition in Alzheimer's disease by Scheltens, Philip, Prins, Niels, Lammertsma, Adriaan, Yaqub, Maqsood, Gouw, Alida, Wink, Alle Meije, Chu, HuiMay, Berckel, Bart N. M., Alam, John

    “…Objective The aim of this study was to preliminarily evaluate an oral small molecule p38α kinase inhibitor in patients with early Alzheimer's disease (AD) for…”
    Get full text
    Journal Article
  13. 13

    An extended amygdala-midbrain circuit controlling cocaine withdrawal-induced anxiety and reinstatement by Tian, Guilian, Hui, May, Macchia, Desiree, Derdeyn, Pieter, Rogers, Alexandra, Hubbard, Elizabeth, Liu, Chengfeng, Vasquez, Jose J., Taniguchi, Lara, Bartas, Katrina, Carroll, Sean, Beier, Kevin T.

    Published in Cell reports (Cambridge) (03-05-2022)
    “…Although midbrain dopamine (DA) circuits are central to motivated behaviors, our knowledge of how experience modifies these circuits to facilitate subsequent…”
    Get full text
    Journal Article
  14. 14

    Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions by Tolbert, Dwain, Bekersky, Ihor, Chu, Hui-May, Ette, Ene I.

    Published in Journal of clinical pharmacology (01-03-2016)
    “…A metabolic mechanism‐based characterization of antiepileptic drug‐drug interactions (DDIs) with clobazam in patients with Lennox‐Gastaut syndrome (LGS) was…”
    Get full text
    Journal Article
  15. 15

    Uncovering the Connectivity Logic of the Ventral Tegmental Area by Derdeyn, Pieter, Hui, May, Macchia, Desiree, Beier, Kevin T

    Published in Frontiers in neural circuits (28-01-2022)
    “…Decades of research have revealed the remarkable complexity of the midbrain dopamine (DA) system, which comprises cells principally located in the ventral…”
    Get full text
    Journal Article
  16. 16

    Identification of pathways that regulate circadian rhythms using a larval zebrafish small molecule screen by Mosser, Eric A., Chiu, Cindy N., Tamai, T. Katherine, Hirota, Tsuyoshi, Li, Suna, Hui, May, Wang, Amy, Singh, Chanpreet, Giovanni, Andrew, Kay, Steve A., Prober, David A.

    Published in Scientific reports (27-08-2019)
    “…The circadian clock ensures that behavioral and physiological processes occur at appropriate times during the 24-hour day/night cycle, and is regulated at both…”
    Get full text
    Journal Article
  17. 17

    An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokinetics by Tolbert, Dwain, Bekersky, Ihor, Chu, Hui-May, Ette, Ene I.

    Published in Journal of clinical pharmacology (01-02-2016)
    “…An integrative population pharmacokinetics (PPK)–based approach was used to characterize the effect of hepatic impairment on clobazam PK and its major…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents by Hasbum, Asbiel, Quintanilla, Jaqueline, Jr, Juan A Amieva, Ding, May-Hui, Levy, Arkene, Chew, Sue Anne

    Published in Future medicinal chemistry (01-02-2021)
    “…Glioblastoma multiforme (GBM) is the most prevalent and aggressive form of glioma, with poor prognosis and high mortality rates. As GBM is a highly…”
    Get full text
    Journal Article
  20. 20